A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2023-09-10
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-12-08 (study day 80); relationship: not assessed
moderate
assessed
Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2024-01-31 (study day 134); relationship: not assessed
mild
assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-03-25 (study day 188); relationship: not assessed
mild
assessed
Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2024-04-15 (study day 209); relationship: N
Data queries
No data queries.